A broken heart is medically real. It has a clinical name, broken heart syndrome, also known as takotsubo cardiomyopathy or stress cardiomyopathy. It causes temporary but significant heart dysfunction that looks almost identical to a heart attack on initial testing. The condition was first identified in Japan in the 1990s and is now recognized worldwide as a genuine cardiac emergency.
What Happens Inside the Heart
When you experience intense emotional or physical stress, your body floods your bloodstream with stress hormones like adrenaline and noradrenaline. In broken heart syndrome, these hormone levels spike to two to three times higher than normal. That surge is essentially toxic to the heart muscle. It causes the left ventricle, your heart’s main pumping chamber, to temporarily weaken and balloon outward in an abnormal shape. The name “takotsubo” comes from a Japanese octopus trap that resembles the distorted shape the heart takes on imaging.
The damage happens through several overlapping pathways. The stress hormones directly injure heart muscle cells, cause tiny blood vessels in the heart to clamp down, and switch the signaling in heart cells from “contract harder” to “contract less.” The result is a sudden drop in the heart’s ability to pump blood effectively. Unlike a traditional heart attack, there’s no blocked artery. The coronary arteries are clean. The heart is being poisoned by its own stress response.
What It Feels Like
Broken heart syndrome mimics a heart attack so closely that even experienced cardiologists can’t distinguish the two based on symptoms alone. You’d feel chest pain, shortness of breath, and potentially dizziness or fainting. An EKG will show changes that look like a heart attack, and blood tests will pick up elevated levels of proteins that signal heart muscle damage.
There are subtle differences on the EKG that can hint at the diagnosis. The electrical changes tend to be less dramatic than in a true heart attack, and certain patterns seen in blocked-artery heart attacks are typically absent. But these are distinctions made in hindsight. In practice, anyone experiencing these symptoms needs emergency care immediately, because there’s no way to tell the difference at home.
Who Gets It
About 90% of broken heart syndrome cases occur in postmenopausal women, making it one of the most sex-skewed conditions in cardiology. The typical patient is a woman in her early 70s (the median age in large studies is 73). The strong association with menopause suggests that declining estrogen levels play a role in making the heart more vulnerable to stress hormone surges, since estrogen normally has protective effects on blood vessels and heart muscle.
Men can develop it too, and when they do, the outcomes are significantly worse. In-hospital mortality for men is 11.2%, compared to 5.5% for women. The reasons aren’t fully understood, but the condition may be underrecognized in men precisely because it’s considered a “women’s disease,” potentially leading to delayed or missed diagnoses.
Triggers Beyond Grief
The name “broken heart syndrome” implies emotional heartbreak, and grief, breakups, and shocking news are classic triggers. But the condition can also be set off by physical stressors: surgery, an asthma attack, a serious infection, or even a car accident. Some cases have no identifiable trigger at all. The common thread is any event that produces a massive adrenaline surge, whether the source is emotional or physical.
How Serious It Is
Broken heart syndrome was once considered relatively harmless because the heart usually recovers. That view has changed. The overall in-hospital mortality rate is about 6.5%, which is not trivial for a condition sometimes dismissed as temporary. More than a third of hospitalized patients (roughly 36%) develop heart failure during their episode. About one in five develops an abnormal heart rhythm called atrial fibrillation. Cardiac arrest occurs in about 3.4% of cases, and stroke in about 5.3%.
These complication rates have actually been climbing in recent years rather than improving. Between 2016 and 2020, mortality rose from 5.6% to 8.4%, and rates of cardiac arrest and heart failure increased as well. Whether this reflects more severe cases being diagnosed or a genuine worsening trend is still being sorted out.
Recovery and What Comes After
The good news is that three out of four patients recover heart function within 10 days. The left ventricle returns to its normal shape and pumping strength, often leaving no permanent structural damage. The remaining 25% take longer than 10 days to recover, and this delayed recovery is associated with worse short-term and long-term survival. For those slower to heal, closer monitoring is typically recommended.
Recurrence is uncommon but real. In a study following 519 patients over a median of about five years, 7.5% experienced at least one additional episode. The median time to a repeat episode was just under three years. Most people who had a recurrence had only one additional episode, though rare individuals experienced two or three. About 1.7% of patients had a recurrence within the first year.
How Doctors Confirm the Diagnosis
Because the symptoms so closely resemble a heart attack, the diagnosis is usually made by ruling out a blockage first. The revised Mayo Clinic criteria require several things to be present: abnormal wall motion in the heart that doesn’t match the territory of a single artery, no evidence of a blocked artery or ruptured plaque on imaging, new EKG changes or mildly elevated markers of heart damage, and the absence of other conditions that could explain the findings (like a tumor of the adrenal glands or inflammation of the heart muscle). In most cases, this means you’ll go through the same initial workup as a heart attack patient, including a cardiac catheterization, before the true diagnosis becomes clear.
Treatment during the acute phase focuses on supporting the heart while it recovers. This can include medications to manage fluid overload and maintain blood pressure, along with close monitoring for dangerous heart rhythms. There is no single targeted drug for the condition, because the underlying mechanism involves multiple overlapping pathways. Management is largely about keeping the patient stable until the heart heals itself.